Location: Home
  • search
  • go
  • Relate News
  • 4/22/2026Chinese Biotech Firms Challenge Western Lead in $16B Parkinson's Treat...
  • 4/16/2026Biogen Maps Long-Term China Partnership Strategy as Cross-Border Innov...
  • 4/14/2026PhRMA Warns U.S. Drug Pricing Policies Could Accelerate China's Rise i...
  • 4/13/2026China Outbound Biopharma Licensing Surges as Global Demand for Innovat...
  • 4/13/2026How Big Pharma's China Trials Are Escaping Scrutiny (The Wire China)
  • 4/9/2026China's Innovative Drug Out-Licensing Surge Tops CNY 400B in Q1 as Gl...
  • 4/9/2026Over Half of China-Listed Drugmakers Grow 2025 Profit as Innovation an...
  • 4/8/2026Global Drugmakers Brace for Another Tough China Year as Beijing Intens...
  • 4/7/2026Pharma Bets Big on Chinese Drugmakers (The Wire China)
  • 4/7/2026Bayer Deepens China Innovation Push as Pharma Division Targets 30% Mar...
  • 3/31/2026NHSA Deepens Dialogue With MNC Pharma on Innovation Drug Value and Rea...
  • 3/27/2026China Pharma Market Set for Structural Shift as Innovation and Cost Pr...
  • 3/25/2026IQVIA Report Highlights Rising Use and Intensifying Competition in Chi...
  • 3/24/2026Global Pharma Ramps Up China Investment as 15th Five-Year Plan Priorit...
  • 3/24/2026Novartis Commits $480M to Expand China Footprint
  • 3/24/2026Chinese Commerce Minister Meets PhRMA, MNC Executives to Discuss Indus...
  • 3/20/2026AstraZeneca Expands UK–China Strategy With Cell Therapy R&D Hub and M...
  • 3/12/2026Almirall Expands China Presence, Seeks More Dermatology Partnerships
  • 2/28/2026bioMérieux CEO Flags "Negative Healthcare Market Evolution" in China
  • 2/26/2026China Pharmaceutical Market Projected to Reach US$573B by 2033
  • 2/25/2026Global Pharma Giants Rush to License Chinese Weight-Loss Drugs, Eye Ob...
  • 2/24/2026CDE Issues Guidelines on Benefit-Risk Assessment Using Multi-Regional ...
  • 2/21/2026Leo Pharma Eyes China Comeback After Decade-Long Launch Drought
  • 2/16/2026Long-Acting Obesity Drugs Drive Record January Licensing Boom for Chin...
  • 2/14/2026Recordati to Withdraw from China After Rare Disease Portfolio Underper...
  • 2/12/2026Today's China Crucible: What It Means for Pharma (PharmExec)
  • 2/10/2026AstraZeneca's China Business Hits New Heights as Record Revenue Boosts...
  • 2/5/2026AmCham China Hosts US FDA Delegation to Strengthen Regulatory Dialogue
  • 2/5/2026Global Pharma in 2025: China Remains a Key Market Amid Rising Competit...
  • 2/3/2026China and USFDA Officials Pledge to Deepen Regulatory Cooperation at B...
  • Page:1/42 Total number of articles:1242: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group